Related Experiment Video

Updated: Aug 6, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

Juvenile dermatomyositis update

Carol B Lindsley1

  • 1Department of Pediatrics, University of Kansas Medical Center, Kansas City, KS 66160-7330, USA. clindsle@kumc.edu

Current Rheumatology Reports
|August 12, 2006
PubMed

Insights

Juvenile dermatomyositis may follow infections, with distinct skin and muscle damage pathways. Methotrexate with corticosteroids aids growth in affected children.

Area of Science:

  • Pediatric rheumatology
  • Autoimmune diseases
  • Dermatology

Background:

  • Juvenile dermatomyositis (JDM) is a rare autoimmune disease affecting children.
  • Understanding JDM's triggers, pathophysiology, and treatment is crucial for improving patient outcomes.

Purpose of the Study:

  • To summarize recent findings on juvenile dermatomyositis.
  • To highlight potential infection triggers, distinct disease mechanisms, and effective therapeutic strategies.

Main Methods:

  • Review of recent studies on juvenile dermatomyositis.
  • Analysis of clinical presentation, pathophysiology, laboratory markers, and treatment outcomes.

Main Results:

  • Most children with JDM exhibit infection-like symptoms before disease onset.
  • Skin and muscle damage in JDM involve separate pathophysiological processes.
  • Urinary muscle metabolites show potential as diagnostic markers.
  • First-line therapy with methotrexate and corticosteroids promotes height velocity and limits BMI increase in JDM patients.

Conclusions:

  • Infection may precede JDM onset, with unique skin and muscle pathologies.
  • Metabolite analysis and combination therapy offer promising avenues for JDM management.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...